March 2025- The University of Texas MD Anderson Cancer Center announced that Jeffrey E. Lee, M.D., an internationally regarded leader in the field of oncology, has been appointed chief medical executive (CME) effective April 1.
Prior to his appointment, Lee served as CME ad interim, demonstrating strength as a leader committed to advancing the institution’s efforts in research, patient care, prevention and education. Assuming the role of CME is the culmination of Lee’s 34-year tenure at the institution, where he has made substantial contributions in the field of oncology and served in multiple leadership roles.
After joining MD Anderson in 1991 as a fellow in surgical oncology, Lee became a member of the faculty and rose through the academic ranks. Since 2010, he has held the endowed Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair.
Also Read : Nemours Children’s Health names Caswell L. Samms III as CFO
“Dr. Lee has demonstrated tremendous capability and talent as a trusted and respected leader,” said Peter WT Pisters, M.D., president of MD Anderson. “His work as interim chief medical executive and substantial contributions to MD Anderson are a testament to his commitment to excellence, and I am confident in his ability to help us navigate the opportunities before us as we work to achieve our mission to end cancer.”
“The opportunity to lead our incredibly talented team of clinicians, scientists and staff is a distinct honor,” Lee said. “Inspired by the needs of our patients and working under our shared mission, I’m committed to guiding our collective efforts to deliver powerful impact for our patients.”
“Remarkably talented as a clinical leader and faculty member, Dr. Lee combines expertise, knowledge of the institution and a passion for our mission, making him an invaluable asset at MD Anderson,” said Stephen G. Swisher, M.D., division head of Surgery at MD Anderson. “He’s an outstanding addition to our executive leadership team whose experience working closely with division heads ensures faculty perspectives are shared and prioritized in institutional decision-making.”
